By vgreene, 11 September, 2020 Proactively ask pt about/evaluate on an ongoing basis for GSM sx, regardless of other tx
By vgreene, 11 September, 2020 If administering low-dose vaginal estrogen, DHEA, or ospemifene: A progestogen is not indicated, but endometrial safety not studied in clinical trials beyond 1y
By vgreene, 11 September, 2020 Choice of tx depends on sx severity, effectiveness and safety of tx for individual pt, and pt preference1
By vgreene, 10 September, 2020 Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With COVID-19 (Metcovid): A Randomised, Double-Blind, Phase IIb, Placebo-Controlled Trial; access Clin Infect Dis article
